Biogen Inc. (BIIB) Price Forecast — AI Targets | MarketCI

Biogen Inc. (BIIB) Price Forecast — AI Targets | MarketCI | MarketCI

BIIB

Market Closed

Biogen Inc.

NASDAQHealthcare Drug Manufacturers - General

7.61K employees

CEO: Christopher A. Viehbacher

Founded: 1991

$196.58

+$0.00(+NaN%)

Market Cap

29.02B

Beta

0.18

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

Biogen’s short-term AI forecast is trending marginally lower, indicating near-term downside risk. Analyst consensus shows strong coverage but wide disagreement, reflecting varied long-term outlooks. This divergence highlights potential volatility amid differing investor expectations.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for BIIB

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore BIIB

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

BIIB in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →